TLR6 and neoplasm: Finally, hypermethylation of Toll-like receptor genes (e.g., TLR4 and TLR6) associated with inflammation (a cancer-related process [19,20,21]) and breast cancer cell survival/proliferation can reduce their expression, thus reducing the inflammatory signaling associated with chronic illness and tumor cell survival [22,23].